Cost-Effectiveness of Pazopanib Versus Sunitinib in Egyptian Patients with Metastatic Renal Cell Carcinoma From the Health Insurance Perspective- A Markov Model

May 1, 2014, 00:00
10.1016/j.jval.2014.03.526
https://www.valueinhealthjournal.com/article/S1098-3015(14)00577-4/fulltext
Title : Cost-Effectiveness of Pazopanib Versus Sunitinib in Egyptian Patients with Metastatic Renal Cell Carcinoma From the Health Insurance Perspective- A Markov Model
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00577-4&doi=10.1016/j.jval.2014.03.526
First page : A90
Section Title : Cancer
Open access? : No
Section Order : 1578
Categories :
Tags :
Regions :
ViH Article Tags :